Thymosin a1

Thymosin a1

Parametr Specyfikacja
Nazwa produktu Thymosin a1
Numer CAS 62304-98-7
Wzór cząsteczkowy C129H215N33O55
Masa cząsteczkowa 3108.3 g/mol
Wygląd White to off-white lyophilized powder
Oznaczenie (HPLC) ≥98%
Rozpuszczalność Rozpuszczalny w wodzie
Opakowanie 1 g / 100 g / 1 kg

Potrzebujesz pomocy? Skontaktuj się z naszym zespołem

Thymosin a1 Structure

Synonimy: Thymalfasin, Zadaxin, Thymosin alpha-1, Tα1, Thymosin α1, Thymalfasin synthetic, Thymosin alpha 1 human

Thymosin a1 is a synthetic 28-amino-acid peptide corresponding to the N-terminal fragment of thymosin alpha-1, a naturally occurring thymic hormone. It is produced by solid-phase peptide synthesis and supplied as a white to off-white lyophilized powder.

Our standard grade is assayed at ≥98% by HPLC, with the sequence verified by mass spectrometry. The powder dissolves readily in water, making it suitable for reconstitution into injectable or liquid formulations.

Buyers typically use this peptide in sterile injectable lines and in research-grade formulations for immune modulation studies. It is also incorporated into specialty nutraceutical and cosmetic preparations where peptide stability and purity are critical.

Applications & Formulation Use

Thymosin a1 is primarily used in the pharmaceutical and biotechnology sectors for the development of injectable immunomodulatory drugs. Formulators reconstitute the lyophilized powder under aseptic conditions for vial filling or lyophilization into finished dosage forms. In research settings, it serves as a reference standard for analytical method development and as an active ingredient in cell-culture studies.

Beyond parenteral applications, the peptide appears in advanced cosmetic serums and creams targeting skin repair, where its water solubility allows easy incorporation into aqueous phases. It is also used in veterinary medicine and as a component in combination therapies for chronic viral infections.

Sourcing & Production

Thymosin a1 is manufactured via solid-phase peptide synthesis starting from protected amino acid derivatives. The crude peptide is purified by preparative HPLC to achieve high purity, then lyophilized to yield the final powder. Production takes place in a controlled environment with strict adherence to GMP guidelines for active pharmaceutical ingredients.

The synthesis route ensures a consistent sequence and avoids animal-derived raw materials, which is important for regulatory compliance and for customers seeking non-animal-origin peptides. Each batch is tested for identity, purity, and peptide content before release.

Bulk Supply & Documentation

  • Opakowanie: 1 g / 100 g / 1 kg
  • MOQ: 1 g
  • Czas realizacji: 3–5 dni roboczych (towary dostępne w magazynie)
  • Dokumentacja: COA and MSDS with every shipment, TDS on request

Contact & Ordering Information

send us your specification for a quotation.

BĄDŹ W KONTAKCIE

Zapytanie ofertowe

Nasz adres

Room,5-0203, Unit 5, Beiyuanmen Street,Xi'an,Shaanxi,China

✅ ×